Suchergebnisse - "Ciccarelli, Olga"

PubPharm (16)

1

Is the central vein sign a useful diagnostic marker for paediatric-onset multiple sclerosis?

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2023

von Abdel-Mannan, O. | Ciccarelli, O.

CommentOn: Mult Scler. 2023 Mar;29(3):475-478. - PMID 36514274

2

Considering the Future of Pediatric Multiple Sclerosis Trials After the CONNECT Open-Label Randomized Trial

enthalten in: JAMA network open | 2022

von Abdel-Mannan, O. | Ciccarelli, O. | Hacohen, Y.

CommentOn: JAMA Netw Open. 2022 Sep 1;5(9):e2230439. - PMID 36169959

3

New Evidence for Epstein-Barr Virus Infection as a Cause of Multiple Sclerosis

enthalten in: Neurology | 2022

von Hacohen, Y. | Ciccarelli, O.

CommentOn: Science. 2022 Jan 21;375(6578):296-301. - PMID 35025605

4

Non-White Participants Matter in White Matter Disease Studies : The Importance of Diversity in Multiple Sclerosis Clinical Trials

enthalten in: Neurology | 2022

von Hamilton, R. | Ciccarelli, O.

CommentOn: Neurology. 2022 Mar 1;98(9):e880-e892. - PMID 35046135

5

A possible case of serum sickness after ocrelizumab infusion - Commentary

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2021

von Al-Araji, S. | Ciccarelli, O.

CommentOn: Mult Scler. 2021 Jan;27(1):155-158. - PMID 32427524

6

Response of the multiple sclerosis community to COVID-19

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2020

von Ciccarelli, O. | Cohen, J. | Thompson, A.

CommentOn: Mult Scler. 2020 Sep;26(10):1153-1156. - PMID 32552382

7

Daclizumab-induced encephalitis in multiple sclerosis

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2019

von Bianchi, A. | Ciccarelli, O.

CommentOn: Mult Scler. 2019 Oct;25(12):1618-1632. - PMID 30657420

8

The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis

enthalten in: Neurology | 2018

von Schoonheim, M. | Ciccarelli, O.

CommentOn: Neurology. 2018 Apr 10;90(15):e1324-e1332. - PMID 29540589

9

Cortico-juxtacortical and periventricular lesions and MS diagnostic criteria

enthalten in: Neurology | 2017

von Svenningsson, A. | Ciccarelli, O.

CommentOn: Neurology. 2017 Dec 5;89(23):2351-2356. - PMID 29101276

10

Can immune reprogramming with alemtuzumab induce permanent remission in multiple sclerosis?

enthalten in: Neurology | 2017

von Wiendl, H. | Bourdette, D. | Ciccarelli, O.

CommentOn: J Clin Pathol. 1988 Apr;41(4):441-3. - PMID 2835401